Vitamin Shoppe Inc. (NYSE:VSI)’s share price shot up 1.6% during mid-day trading on Tuesday . The stock traded as high as $28.16 and last traded at $27.97, with a volume of 211,912 shares trading hands. The stock had previously closed at $27.54.

Several research firms recently issued reports on VSI. Macquarie reiterated a “neutral” rating and issued a $40.00 target price on shares of Vitamin Shoppe in a research note on Thursday, May 5th. Goldman Sachs Group Inc. cut shares of Vitamin Shoppe to a “hold” rating in a research note on Saturday, April 30th. Robert W. Baird reiterated a “hold” rating on shares of Vitamin Shoppe in a research note on Tuesday, April 26th. Wedbush began coverage on shares of Vitamin Shoppe in a research note on Wednesday, April 20th. They issued an “outperform” rating and a $39.00 target price for the company. Finally, Jefferies Group reiterated a “hold” rating and issued a $32.00 target price (up from $30.00) on shares of Vitamin Shoppe in a research note on Friday, May 6th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the company’s stock. Vitamin Shoppe presently has an average rating of “Hold” and a consensus target price of $32.82.

The stock has a 50 day moving average price of $29.76 and a 200-day moving average price of $29.74. The firm has a market capitalization of $621.91 million and a price-to-earnings ratio of 15.45.

Vitamin Shoppe (NYSE:VSI) last announced its earnings results on Wednesday, August 3rd. The company reported $0.55 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.59 by $0.04. The firm had revenue of $332.70 million for the quarter, compared to analyst estimates of $331.58 million. During the same quarter in the previous year, the business posted $0.57 EPS. The company’s revenue was up 3.2% on a year-over-year basis. On average, equities research analysts forecast that Vitamin Shoppe Inc. will post $2.17 EPS for the current fiscal year.

In related news, Director Guillermo Marmol purchased 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 31st. The stock was purchased at an average cost of $30.23 per share, with a total value of $30,230.00. Following the completion of the acquisition, the director now directly owns 1,470 shares in the company, valued at $44,438.10. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link.

A hedge fund recently raised its stake in Vitamin Shoppe stock. Rhumbline Advisers increased its stake in Vitamin Shoppe Inc. (NYSE:VSI) by 4.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 45,118 shares of the company’s stock after buying an additional 1,855 shares during the period. Rhumbline Advisers owned 0.16% of Vitamin Shoppe worth $1,475,000 as of its most recent SEC filing.

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.